If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,990.00    32.00 (1.63%)
Bid:
1,994.00
Ask:
1,997.00
Spread: 3.00 (0.15%)
Market Cap: £2.22b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Annual Financial Report

14 Apr 2026 11:14

RNS Number : 4229A
Derwent London PLC
14 April 2026
Β 

For immediate release

Β 

Β 

Derwent London plc ("Derwent London" / "the Group") Β Notice of the 2026 Annual General Meeting ("AGM") andpublication of the 2025 Report & Accounts and the 2025 Responsibility Report

Β 

Notice of 2026 AGM and 2025 Report & Accounts

Derwent London announces that copies of the Notice of the 2026 AGM and 2025 Report & Accounts have been made available to shareholders and can be viewed and downloaded on the Group's website www.derwentlondon.com

Β 

Copies of these documents, together with the Form of Proxy for the AGM, will be submitted to the National Storage Mechanism (via the Electronic Submission System) shortly.

Β 

In accordance with Rule 4.1.15R of the Disclosure and Transparency Rules, the Group has published its 2025 Report & Accounts in Extensible Hypertext Markup Language (XHTML) and key elements of its financial statements have been 'tagged' using Extensible Business Reporting Language (XBRL) markup language. This version of the 2025 Report & Accounts will also be submitted to the National Storage Mechanism and is available on our website.

Β 

In accordance with Rule 4.1.3R of the Disclosure and Transparency Rules, the Group published its annual results for the year ended 31 December 2025 on 26 February 2026.

Β 

2026 AGM

As set out in the Notice of the 2026 AGM, the Group's 42nd AGM will be held on 15 May 2026 at 9:30 am. The Directors look forward to meeting with shareholders in person.

Β 

It would be helpful to the smooth running of the AGM if questions could be submitted to the Company Secretary, David Lawler, at company.secretary@derwentlondon.com, up to one day before the commencement of the AGM.

Β 

2025 Responsibility Report

The 2025 Responsibility Report, and associated Data Report workbook, have also been published today and are available to be viewed at www.derwentlondon.com/responsibility/publications

Β 

Β 

Enquiries:

D A Lawler

Company Secretary

14 April 2026

Β 

020 7659 3000

www.derwentlondon.com

Β 

Notes to editorsΒ 

Β 

Derwent London plc

Β 

Derwent London plc owns a commercial real estate portfolio predominantly in central London valued at Β£5.1 billion as at 31 December 2025, making it the largest London office-focused real estate investment trust (REIT).

Β 

Our experienced team has a long track record of creating value throughout the property cycle by regenerating our buildings via redevelopment or refurbishment, effective asset management and capital recycling. We typically acquire central London properties off-market with low capital values and modest rents in improving locations, most of which are either in the West End or City Borders. We capitalise on the unique qualities of each of our properties - taking a fresh approach to the regeneration of every building with a focus on anticipating tenant requirements and an emphasis on design. Reflecting and supporting our long-term success, the business has a strong balance sheet with modest leverage, a robust income stream and flexible financing.

Β 

We are frequently recognised in industry awards for the quality, design and innovation of our projects. Landmark buildings in our 5.3 million sq ft portfolio include 25 Baker Street W1, 1 Soho Place W1, 80 Charlotte Street W1, Brunel Building W2, White Collar Factory EC1, Angel Building EC1 and Tea Building E1.

Β 

As part of our commitment to lead the industry in mitigating climate change, Derwent London has committed to becoming a net zero carbon business by 2030, with its updated pathway published in 2025. Our science-based carbon targets have been validated by the Science Based Targets initiative (SBTi). In 2013, we launched a voluntary Community Fund which to date has supported 200 community projects in central London.

Β 

The Company is a public limited company, which is listed on the London Stock Exchange and incorporated and domiciled in the UK. The address of its registered office is 25 Savile Row, London, W1S 2ER.

Β 

For further information see www.derwentlondon.com or follow us on LinkedIn.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
ACSUSARRNRUSAAR
Date   Source Headline
20th Dec 20133:40 pmRNSHolding(s) in Company
16th Dec 20133:09 pmRNSHolding(s) in Company
6th Dec 20133:00 pmRNSHolding(s) in Company
27th Nov 20135:55 pmRNSHolding(s) in Company
21st Nov 201311:00 amRNSBlocklisting Interim Review
13th Nov 20137:00 amRNSQ3 Interim Management Statement
4th Nov 201312:30 pmRNSNotice of Interim Management Statement
1st Nov 20133:00 pmRNSTotal Voting Rights
21st Oct 20135:00 pmRNSAdditional Listing
8th Oct 201311:15 amRNSHolding(s) in Company
4th Oct 20132:00 pmRNSHolding(s) in Company
2nd Oct 20133:00 pmRNSTotal Voting Rights
1st Oct 20139:59 amRNSInvestor Presentation
1st Oct 20139:58 amRNSRefinancing
27th Sep 20135:15 pmRNSBlocklisting Interim Review
25th Sep 20133:15 pmRNSScrip Dividend Scheme
15th Aug 20137:00 amRNSInterim Results
6th Aug 201312:15 pmRNSDirectorate Change
19th Jul 201311:47 amRNSSale of interest in 1-5 Grosvenor Place SW1
17th Jul 20132:29 pmRNSFinal Terms of Convertible Bond Offering
17th Jul 20137:00 amRNSAnnouncement re: Convertible Bond Offering
2nd Jul 201310:30 amRNSTotal Voting Rights
27th Jun 20131:30 pmRNSHolding(s) in Company
19th Jun 20137:00 amRNS1-5 Grosvenor Place SW1
13th Jun 20139:00 amRNSLetting Update
12th Jun 20133:45 pmRNSAdditional Listing
5th Jun 201312:50 pmRNSTotal Voting Rights
5th Jun 201312:46 pmRNSBondholder meeting
5th Jun 201312:45 pmRNSHolding(s) in Company
21st May 201311:15 amRNSHolding(s) in Company
21st May 201310:30 amRNSBlocklisting Interim Review
17th May 20135:00 pmRNSResult of AGM
15th May 20132:00 pmRNSScrip Dividend Scheme
10th May 20139:30 amRNSHolding(s) in Company
10th May 20137:00 amRNSInterim Management Statement
7th May 201310:15 amRNSNotice of Interim Management Statement
1st May 20134:30 pmRNSTotal Voting Rights
19th Apr 20133:00 pmRNSDirector/PDMR Shareholding
19th Apr 20133:00 pmRNSDirector/PDMR Shareholding
19th Apr 20133:00 pmRNSDirector/PDMR Shareholding
19th Apr 20133:00 pmRNSDirector/PDMR Shareholding
19th Apr 20133:00 pmRNSDirector/PDMR Shareholding
19th Apr 20133:00 pmRNSDirector/PDMR Shareholding
18th Apr 20139:00 amRNSDocuments available at NSM
8th Apr 20134:30 pmRNSDirector/PDMR Shareholding
8th Apr 20134:30 pmRNSDirector/PDMR Shareholding
8th Apr 20134:30 pmRNSDirector/PDMR Shareholding
8th Apr 20134:30 pmRNSDirector/PDMR Shareholding
8th Apr 20134:30 pmRNSDirector/PDMR Shareholding
8th Apr 20134:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.